← Leaderboards
Stephane Lajoie
Johns Hopkins University
$4,307,669
Attributed
$4,307,669
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $630K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,307,669 · 3
By mechanism
R01$3,902,669 · 2
R56$405,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Robert P Schleimer$28,154,309
- Andrew P Lane$17,085,410
- Bruce S Bochner$17,391,451
- Murugappan Ramanathan$3,489,520
- Alkis G. Togias$2,883,948
Others in their field
Top investigators on “Allergic Airway Disease”
- James E. Gern · University Of Wisconsin-Madison$62,436,928
- Daniel J Jackson · University Of Wisconsin-Madison$28,644,793
- William W. Busse · University Of Wisconsin Madison$26,414,194
- Fernando D Martinez · University Of Arizona$23,352,918
- Hirohito Kita · Mayo Clinic Arizona$20,982,368
- Yvonne M.w. Janssen-Heininger · University Of Vermont &St Agric College$17,018,749
Research focus
Allergic Airway DiseasePathway InteractionsAllergensInterleukin-13ModalityPathogenesisResponseSignal TransductionReceptorInflammatory ResponseLungMediatingAllergic DiseaseNovel TherapeuticsAllergicRegulationAllergic ResponsePrevalenceInflammationImpairmentPublic Health RelevanceCellsLigandsPyroglyphidae
Grant awards (9)
Neuronally-driven accumulation of glycolytic MafB+MHCIIhi IMs drive airway allergy$619,322
R01 · FY2025 · AI · contact PI
Neuronally-driven accumulation of glycolytic MafB+MHCIIhi IMs drive airway allergy$629,984
R01 · FY2024 · AI · contact PI
Neuronally-driven accumulation of glycolytic MafB+MHCIIhi IMs drive airway allergy$607,269
R01 · FY2023 · AI · contact PI
Dysregulated sensing of invertebrate tropomyosin through dectin-1 confers susceptibility to type-2-mediated allergic diseases$409,375
R01 · FY2021 · AI · contact PI
Dysregulated sensing of invertebrate tropomyosin through dectin-1 confers susceptibility to type-2-mediated allergic diseases$409,375
R01 · FY2020 · AI · contact PI
Dysregulated sensing of invertebrate tropomyosin through dectin-1 confers susceptibility to type-2-mediated allergic diseases$409,375
R01 · FY2019 · AI · contact PI
Dysregulated sensing of invertebrate tropomyosin through dectin-1 confers susceptibility to type-2-mediated allergic diseases$409,323
R01 · FY2018 · AI · contact PI
Dysregulated sensing of invertebrate tropomyosin through dectin-1 confers susceptibility to type-2-mediated allergic diseases$408,646
R01 · FY2017 · AI · contact PI
Anaphylatoxin regulation of the IL-33-ILC2 axis$405,000
R56 · FY2016 · AI · contact PI